OBJECTIVES: Utilization of bilateral internal mammary arteries (BIMAs) has been shown to improve long-term outcomes in patients undergoing coronary artery bypass grafting. To achieve complete revascularization, BIMAs may be used as either sole conduits for revascularization through a Y-graft configuration (BIMA-Y) or deployed with additional grafts used in conjunction with BIMAs. The purpose of this study was to compare the long-term outcomes of two institutions that predominantly used either the BIMA-Y configuration or BIMA plus additional grafts to achieve optimal revascularization.
INTRODUCTION
Coronary artery bypass grafting (CABG) is performed with the intention of accomplishing complete revascularization of the coronary system, leading to long-lasting beneficial results without increasing short-term complications. Recent literature supports the improved long-term survival obtained by utilizing bilateral internal mammary arteries (BIMAs) over the standard left internal mammary artery (LIMA) with saphenous vein grafts (SVG) [1] [2] [3] [4] . This improved survival seen in patients receiving BIMAs is the result of many factors, including higher mid-and long-term patency rates of mammaries versus veins [5] , and a beneficial effect of arterial grafts placed onto the distal coronary beds [6] . Despite these findings, bilateral internal thoracic arteries are utilized in a minority of patients undergoing coronary artery surgery. According to the Society of Thoracic Surgeons Database, in over 540 000 patients undergoing coronary artery bypass in 745 institutions, only 4% received bilateral internal thoracic artery grafting [7] . Although there are many possible contributors to this underutilization of BIMA grafting, an important factor is the uncertainty about optimal configuration of the two internal mammary arteries (IMA). Two configurations of the right IMA (RIMA) are most frequently utilized ( Table 1 ). The first is the in situ configuration. This approach allows the IMA to remain attached to its origin but only a single, more proximal branch of the circumflex or the left anterior descending can be revascularized due to limited conduit length . An alternative approach is Y-grafting in which the free RIMA is proximally anastomosed to the left IMA at the level of the left atrial appendage. This approach allows for multiple branches of the circumflex coronary artery and some branches of the right coronary artery to be revascularized with the RIMA in a sequential manner (Table 1) . Potential disadvantages of this approach are the dependence of the Y-construct on a single inflow [8] and that the anastomoses can be more technically difficult. There is a clear difference between a potentially more challenging operation, the BIMA-Y graft with multiple sequential distal anastomoses, and a more simple use of each single mammary artery to bypass individual distal targets with the addition of other conduits as needed. This difference resides in the fact that each technique provide varying degrees of myocardial mass reperfused through IMA grafting. The impact of additional grafts on patient survival varies greatly depending on the conduit chosen in addition to the IMAs [9, 10] .
In this manuscript, we are not addressing whether we should or should not use BIMAs versus single internal mammary artery (SIMAs) but a more complex issue, involving how to best implement BIMA grafting. Towards this goal, we have selected two institutions which predominately use two distinct approaches to BIMA utilization. We have analysed the short-and long-term outcomes of these two groups, which reflect the use of these two distinct surgical approaches.
METHODS

Study design
This was a retrospective analysis of data collected prospectively at two institutions (Valley Hospital in Ridgewood, New Jersey and St Luc Bouge group in Belgium). Each institution used a standard cardiac registry to collect and manage data. All variables that were common across institutions were defined using the standard definitions published by the Society of Thoracic Surgeons.
Patient demographics
From 2000-2010, a consecutive series of 3121 patients underwent CABG for three or more vessels at the Valley Hospital (Group A). This group contained a wide variety of surgeon specific grafting strategies, with 23% of patients receiving BIMA grafting. Overall, 436 of these patients were operated on for triple vessel disease utilizing BIMA with additional SVGs. Off-pump CABG was utilized in 81.0% of cases. In all cases, a LIMA and a RIMA were used to graft the left and/or right coronary branches. Throughout this period, no BIMA-Y grafts were utilized by Group A, and vein grafts were employed to complete full revascularization of all distal targets that could not be grafted by the two mammary arteries.
From 2000-2010, the St Luc Bouge group in Belgium (Group B) performed isolated CABG on a consecutive series of 2057 patients. Off-pump platform was utilized in 97.4% of cases, with a smaller portion requiring on-pump surgery either due to admission to the operating room in cardiac arrest (15 patients, 0.7%) or requiring conversion from off-pump to on-pump (37 patients, 1.8%). BIMA-Y grafting was by far the predominant strategy in Group B and, after 2003, became the institutional standard for all patients undergoing CABG below 80 years of age. Within Group B, 771 (37.5%) had three vessel disease and were revascularized solely through an off-pump BIMA-Y configuration, treated with only BIMA-Y configuration without the addition of any other conduits. In this group, a RIMA was used to graft the left circumflex and right coronary territories.
Statistical analyses
Categorical and continuous data are reported as percentages and means with standard deviations, respectively. Categorical variables were compared using the Chi-square test or Fisher's Exact Test when this statistic was computed due to insufficient number of events or observations. Continuous data between groups were compared using the Student's unpaired t-test and ordinal data compared with the Mann-Whitney U test. Late survival comparing groups using single variables was performed using Kaplan-Meier analysis. Cox proportional hazards regression analysis was used to compare Groups A and B on late allcause mortality, controlling for multiple baseline covariates. The baseline covariates that were used included gender, age (years), obesity (defined as body mass index < 30), diabetes, history of smoking, hypertension, hypercholesterolemia, peripheral vascular disease, New York Heart Association (NYHA) class III or IV, unstable angina, family history of cardiovascular disease, history of myocardial infarction (MI) (within 3 months prior to surgery), renal failure, left main disease, left ventricular ejection fraction (%), number of distal anastomoses and urgent or emergent status. Hazard ratios and their 95% confidence intervals (CI) were estimated using the Cox model. Assumptions for proportional hazards were tested by including main effects and product terms of the covariates and logarithmic-transformed time factor, and log-log plots were analysed, which demonstrated that there was no evidence to reject the null hypothesis that the proportional assumptions were violated. A value of P less than 0.05 was considered to be statistically significant. Statistical analyses were performed using IBM/SPSS IBM Corp. 
Study outcomes
The primary outcome of the study was long-term survival, which was defined as freedom from mortality from any cause during • Each IMA is used in situ and therefore is able to consistently provide sufficient blood flow to each target vessel
• The RIMA does not cross the midline of the chest in front of the aorta in case of redo sternotomy
• LIMA to LAD configuration (gold standard) is maintained
• When using the RIMA through the TS, the length savings obtained allow it to reach the circumflex territory for grafting of proximal and distal marginal branches used to cross the chest to reach the circumflex territory enables the grafting of medial or distal marginal branches
• This approach mandates the entire length of the RIMA to be used, Therefore the mammary available at the anastomotic site is often small and very muscular, which has been identified as a factor leading to worse patency
• The possibilities of making sequential anastomosis are limited due to the short RIMA length
• If multiple marginal branches have to be grafted, an accessory graft is necessary
In situ LIMA to LCX In situ RIMA to LAD
• Each IMA is used in situ and therefore is able to consistently provide sufficient blood flow to each target vessel
• The LIMA can re-vascularize several branches of the circumflex system, avoiding the need for an accessory graft for the circumflex system
• The RIMA crosses the midline of the chest anterior to the aorta, increasing the risk of graft injury during future re-etery
• If the LAD needs to be grafted distally, the length of the RIMA may not be sufficient follow-up, and the time to event was defined as the time from date of initial surgery to the date of latest patient contact. All-cause late mortality was determined using the Social Security Death Index for patients in Group A and through a pre-specified institutional protocol for Group B, which insured that patients were seen every year after their initial revascularization procedure and included questionnaires about health status, symptoms, noninvasive testing, need for any further revascularization therapies and hospitalizations required. In Group A, 99.3% of patients were followed for a mean time of 7.2 ± 3 years (range 0.1-16 years), with 0.7% lost to 30 day in-hospital mortality. In Group B, 99.0% of patients were followed for a mean time of 8.1 ± 3 years (range 0.1-15 years), with 1.0% lost to 30-day in-hospital mortality. The only common late outcome across both institutions was late all-cause mortality, which was used as the primary outcome for the study. In addition to the primary outcome, Groups A and B were also compared on postoperative in-hospital and 30-day adverse events. These included death up to 30 days after surgery, permanent stroke, deep sternal wound infection, reoperation for bleeding, and new onset occurrence of atrial fibrillation (not present prior to surgery). All outcomes were defined using standard society of thoracic surgery (STS) definitions.
RESULTS
Groups A and B were compared and found to have a number of differences in preoperative characteristics (Table 2) . Patients in Group A were significantly younger, more likely to be male, with a history of smoking, hypercholesterolemia, obesity, MI in the prior 3 months, family history of cardiovascular disease and significant left main disease. Group B patients were more likely to be diabetic, with a history of renal failure, peripheral vascular disease and NYHA Class III/IV heart failure. Patients in Group A received, on average, two less arterial grafts than patients in Group B, with the right coronary region and the branching segments of the LAD (diagonals) consistently receiving venous grafting (Table 3) . Groups A and B did not have a statistically significant difference in mean number of anastomotic sites (A = 4.0 ± 0.7 vs B = 4.0 ± 0.7; P = 0.24). The groups did not differ significantly based on in-hospital mortality, permanent stroke, deep sternal wound infection and reoperation for bleeding (Table 4) . Group B patients did have a significantly higher rate of postoperative atrial fibrillation (P < 0.001).
Patients were followed for a mean of 7.8 years (range 0.1-16 years). Late all-cause mortality occurred in 46 (10.6%) of Group A patients and 88 (11.4%) of Group B patients. An initial unadjusted univariate Kaplan-Meier analysis showed no significant difference between survival in Groups A and B (P = 0.097). Cox proportional hazards regression analysis, using all 17 base co-variates including pump status, demonstrated that Group B had a significantly improved survival compared to Group A (Group B = 88% vs Group A = 81%) with an overall reduction in mortality (adjusted hazard ratio 0.780, 95% CI 0.448-0.849; P = 0.043) ( Table  5) , with a survival difference between Group A and Group B at 14 years of 81% and 88%, respectively (Fig. 1) . Further Kaplan-Meier analyses, performed separately on Groups A and B and then stratified by group, showed that patients with postoperative atrial fibrillation did not differ significantly in regards to late all-cause mortality (P = 0.24 and P = 0.08, respectively). Cox proportional hazards regression analysis, with survival time calculated from discharge date to last patient contact and including the 17 baseline covariates and in-hospital postoperative Afib, showed that while postoperative Afib was independently associated with an increase in late mortality, Group B patients still had a significant benefit in survival (P = 0.046) that was independent of the occurrence of postoperative Afib.
DISCUSSION
Overall the use of the BIMA-Y configuration, as routinely performed by Group B, provided improved long-term survival when compared to BIMA with additional SVGs, as performed by Group A. Use of the BIMA-Y configuration, through the performance of multiple sequential anastomoses, resulted in total arterial revascularization, providing twice the number of distal arterial anastomoses when compared to the use of BIMA plus SVG in a nonsequential manner ( Table 3 ). As such, it appears that the protective effects of the BIMA are somewhat proportional to the number of distal anastomoses created with each of the two mammary arteries.
Both groups represent intrinsic differences with regards to the anastomotic technique and the utilization of the two mammary arteries. In Group A, BIMAs were used as in situ configurations to assure every IMA target receives an independent in-flow. However, as the in situ RIMA may not be long enough to adequately graft the right system, additional non-IMA grafts may be required to assure complete revascularization (Table 1) . In this cohort, Group A chose to utilize additional vein grafts in a nonsequential manner. This consistent use of an end-to-side anastomosis and choice of SVGs as additional grafts, make the operation technically easier; however, it sacrifices the potential longterm patency and protection provided by utilization of the two mammary arteries
By comparison, Group B demonstrated an institutional preference for a BIMA-Y configuration with sequential grafting to assure complete arterial revascularization. In this configuration, a free-RIMA is anastomosed off of the LIMA at the level of the left atrial appendage with multiple sequential grafts. While full revascularization using the BIMA-Y construct assures all targets receive the protective qualities of mammary arteries, it does require the operator be comfortable performing multiple sequential grafts and adds new technical challenges to the surgical strategy.
While the BIMA-Y construct has been associated with improved long-term survival, it does require a surgical strategy of revascularization that is greatly influenced by the severity of the native coronary stenosis. In this study, we do not report the functional degree of stenosis in the different areas grafted, as functional flow reserve (FFR) was not routinely used as an objective method of assessing the functional degree of a stenosis throughout either the American (Group A) or European (Group B) cohorts. Although the BIMA-Y approach appears to be a safe and reproducible technique, the rate of competitive flow when using this configuration is higher than when using the in situ configuration. Glineur et al [11] have studied this phenomenon and concluded that the function of the RIMA, when used as a Y-graft, was significantly improved when used on severely stenosed branches of the circumflex arteries or distal branches of the right coronary artery.
There are situations where complete BIMA utilization is not ideal. These include instances when the stenosis of any target is <70%, including the left main. In these cases, the surgeon may choose to utilize a BIMA with additional non-internal mammary artery (non-IMA) grafts to complete the procedure for targets with non-severe stenosis. While the use of BIMA-SVG resulted in lower long-term survival in this study, alternative non-IMA conduits, such as the radial artery or the gastroepiploic artery, may provide superior results to the use of a vein as an alternative conduit, as long as they are grafted to highly stenosed vessels. Grau et al. [12] recently investigated the impact of the radial artery when used in conjunction with BIMAs, finding that patients with BIMA + radial had a trend towards improved survival after 10 years when compared to patients receiving BIMA + SVG. Similarly, Glineur et al. [13] found that the addition of a gastroepiploic artery to a BIMA graft provides superior 25 year survival than an additional SVG when the gastroepiploic artery (GEA) was grafted to a target with >73% stenosis. Larger cohorts of patients with longer follow-up are necessary to substantiate these outcomes.
The primary concern of any CABG operation is to assure complete revascularization without introducing undue risks, as incomplete revascularization can lead to a significant increase in longterm morbidity and mortality [14] . This is particularly a concern in cases of off-pump CABG, as several recent publications show decreased rates of complete revascularization when CABG is performed in an off-pump manner. In a long-term trial comparing on-pump and off-pump CABG, Kim et al. [15] found that patients undergoing revascularization in an off-pump manner received a significantly lower number of target vessel bypasses. Similarly in a meta-analysis, Takagi et al. [16] found that in 8 out of 16 studies an on-pump approach was associated with a significantly greater number of grafts, and resulted in a greater frequency of complete revascularization in 6 out of 8 studies. However, off-pump surgery does not appear to carry an increased risk of mortality as long as patients receive complete revascularization [17, 18] .
Both groups of operators in this study primarily performed CABG in an off-Pump manner, as it is the preferred strategy at their respective institutions. This approach has been shown to reduce the short term risk of stroke, blood utilization and/or atrial fibrillation [19] . Off-Pump CABG can increase the technical difficulty of the revascularization procedure, particularly in the case of BIMA-Y grafting, which requires multiple sequential grafting. As shown by Glineur et al. [20] in a prospective randomized trial, the patency rates between BIMA-Y and in situ BIMA grafting are similar at 6 months. However, the choice to perform CABG offpump did not appear to have a negative effect on the number of distal anastomoses or general outcomes at either institution (A = 4.0 ± 0.7 vs B = 4.0 ± 0.7). This further substantiates the decision to not exclude on-pump patients in Group A from our analyses, since it is unlikely that pump status would substantially impact late survival and we felt there was an advantage to keeping the on-pump patients in the analyses considering that Group A was smaller than Group B. Both groups had a low incidence of perioperative events (Table 4 ) and long-term survival was comparable to what is reported in the literature.
Current European society of cardiology/European association of cardiothoracic surgery (ESC/EACTS) guidelines suggest physicians consider the utilization of arterial grafts in two instances, as bilateral internal thoracic artery (BITAs) in patients <70 year of age and in the form of total arterial revascularization when patients have reasonable life expectancy. Both of these statements have been given a Class IIa recommendation. There is no specific recommendation with regards to the exact configuration of how to use these arterial grafts [21] . This manuscript addresses these recommendations by comparing the long-term survival benefits of two specific constructs. The BIMA-Y configuration with multiple sequential anastomoses used to achieve full arterial revascularization and a BIMA-SVG with multiple non-sequential anastomoses. Overall our finding that the BIMA-Y configuration provided superior long-term survival compared to the BIMA-SVG in our institutions, suggests that greater emphasis should be placed on the attainment of full arterial revascularization. Furthermore, these results suggest that a Y-configuration can provide excellent longterm survival and protection against long-term major adverse cardiac and cerebrovascular events (MACCE) in the setting of offpump CABG.
At the present time, we do not have any long-term data from a prospective randomized study assessing the impact of arterial revascularization. The arterial revascularization trial (ART) trial has already delivered its 1-year results in 2010 and constitutes the only randomized multi-institutional study on this topic [22] . Grau et al. [1] have previously published their own results regarding the utilization of BIMAs. However, as single institutional reports are limited by their very nature, we have included in our analysis a second institution (Group B) with known tradition in the use of off-pump BIMAs during CABG. We feel we have found a potentially comparable cohort of patients operated on by surgeons skilled in both the use of BIMAs, as well as the use of the off-pump platform.
Currently only 4% and 12% of patients in the USA and Europe respectively receive BIMA [7, 23] . This represents a clear discrepancy between actual clinical practice and guideline recommendations with regards to the use of arterial conduits, specifically BIMAs. In recent years, the two institutions involved in this study have embraced a significant use of BIMA conduits during CABG, with last figures showing approximately 50% utilization in Group A and 90% in Group B. This substantiates these surgeons' preference towards BIMA utilization as the conduit of choice for coronary revascularization.
Recent literature has focused on studies which have compared the use of BIMAs versus LIMA-SVG as alternative approaches to coronary revascularization. This study instead compares two strategies incorporating BIMA use during CABG and evaluates whether the increased number of anastomosis performed with the two IMA arteries provides superior long-term survival. Our results indicate that the percentage of myocardium revascularized with BIMAs seems to have a positive effect on long-term follow-up. Future studies should specify, not only whether BIMAs were used but also information about the number of distal targets bypassed with internal mammary arteries
LIMITATIONS
We were unable to control for the surgeon performing each operation or the operating team. Based on what we know about each institution, both have experienced cardiothoracic surgeons and managing teams, versed in BIMA and off-pump surgery. The patients selected for this study from either institution represent only a portion of patients selected for CABG, which limits the generalizability of this finding to other surgical approaches.
The two patient groups differed in demographics, (e.g., age) and important clinical characteristics which we attempted to control for using accepted statistical techniques. Group B had more characteristics which were found to be predictors of late mortality and thus may have had a higher risk profile; however, the Cox regression model was used to control for these factors and establish whether a difference in surgical strategy outcome remained. In our analysis, we compared two institutions which reflected two different approaches to BIMA grafting; however, other institutional differences, which we were unable to control for, may have affected the results. Also, we were not able to characterize the degree of coronary artery stenosis since we did not have comprehensive cardiac catheterization data at both institutions. One of the limitations inherent to this study is that the follow-up was different between either groups; however, a commonality was found in the all-cause mortality. Finally, the accuracy of social security death index (SSDI) in recent years has been limited by the legislative removal of recent deaths, further emphasizing the impact of age on survival within the American cohort. Since our study covers a time period before the legislative change, this is unlikely to have an effect on our results.
CONCLUSION
In this study, utilization of the BIMA-Y configuration was associated with improved survival when compared to BIMA grafting with additional vein grafts. This finding may be related to the number of distal coronary anastomoses provided by the internal mammary arteries. Further studies are necessary to evaluate the efficacy of BIMA-Y grafting against other means of providing complete arterial revascularization.
APPENDIX. CONFERENCE DISCUSSION
Dr P. Davierwala (Leipzig, Germany):
This paper discusses the best configuration strategy for utilizing bilateral internal mammary arteries. This question is of extreme importance in the present era of overwhelming use of percutaneous coronary intervention, the studies pertaining to which consider 5-year outcomes as long term. We as surgeons should strive to improve, what I consider extended long-term outcomes in patients undergoing coronary artery bypass graft surgery. So in light of this, the present study carries a great significance as it not only assumes that the use of bilateral internal mammary artery is mammary artery grafting, using Y-composite graft which can give better outcomes when compared to bilateral internal mammary arteries used as in situ grafts with additional vein graft revascularization.
This study included two groups of patients with three-vessel disease from two institutions undergoing coronary artery bypass graft surgery with bilateral internal mammary arteries. Because of significant intergroup differences, a propensity score was created to adjust for these differences when comparing these two groups. Postoperative mortality and complications were very low and no differences were found in the outcomes between the two groups, in the unmatched cohorts, except for the difference in postoperative atrial fibrillation, which occurred more frequently in the bilateral internal mammary arteries-Y group. After a mean followup of 7.8 years, ranging between 1 and 16 years, no difference in survival was found in the unmatched groups; however, after adjusting for baseline group differences, the authors did find that bilateral internal mammary arteries-Y strategy had a better long-term survival of 88% as compared to 81% in patients with the in situ bilateral internal mammary arteries plus vein graft strategy.
I would like to congratulate the authors not only on performing the study but more importantly on the excellent results and particularly the drive in their institution towards greater utilization of bilateral internal mammary arteries and off-pump coronary artery bypass interventional cardiology technique. Additionally, the results that they've achieved long term are really commendable. This should be the trend that the majority of the surgeons today should follow, especially the young surgeons in the crowd.
Having said that, I would like to ask you a couple of questions, two of them directly related to the study itself and a couple of questions which are more practical for everyday practice.
Was there any difference in immediate postoperative outcomes after the groups were matched, especially with respect to myocardial infarction and repeat interventional or surgical revascularization?
My second question is: When we discuss the optimum configuration of grafts for a particular patient, it's always with the idea of having the best possible long-term patency for every native vessel that is grafted. This can only be proved by long-term follow-up angiography, which we all agree, is quite difficult to achieve. So the best possible correlate to that is performing a clinical follow-up.
Your study does present a long-term survival, but that does not represent long-term patency. Therefore, I would like to ask you, if you have data regarding freedom from cardiac death, freedom from myocardial infarction, and freedom from repeat revascularization, which would come close to giving us an idea about patency of grafts?
Those are two questions related to the study. Now the two practical questions. You have only 15% of the patients in the BIMA-Y group with left main disease. Are you hesitant in performing the BIMA-Y strategy for left main disease and if so, at what percentage of left main stenosis would you be comfortable doing a complete Y strategy?
And second, as mentioned in your study, you do not have the preoperative degree of coronary stenosis. Do you recommend BIMA-Y grafting for all patients irrespective of the degree of stenosis, or would you hesitate to perform this strategy in patients in whom the last coronary vessel to be grafted has a lower grade stenosis than the upstream native vessels?
Dr Glineur: Thank you very much for very interesting questions. To respond to your first question, there were no major significant differences in the hospital event after adjustment at 90 days in terms of mortality or morbidity.
To respond to your second question, in fact the problem is that we have two different cohort of patients. We have a cohort of patients from Belgium in whom we have all the data, the postoperative long-term major adverse cardiac coronary event; but the American population is much, much, much, much harder to obtain the major adverse cardiac coronary event at long term, whereas it's very easy to have the survival, it's part of the American system. So that's the reason why we did not compare both.
But the paper with the 800 patients with the long-term follow-up is in press in the European journal with the long term major adverse cardiac coronary event which is going to be published, so definitely this will be published and you can have the information of the long-term follow-up major adverse cardiac coronary event in the Y-graft configuration group.
To respond to your third question concerning the left main configuration, as long as the eyeballing of the surgeon and of the cardiologist estimates that the left main is significant, we will use a Y-graft configuration. And it means that the left main stenosis is at least more than 60%. But it's true that when you do this surgery off pump and when you open the left anterior descending, sometimes you have the blood that touched the roof of the ceiling, so it's true that you have higher competition rate than when you have a clear fractional flow reserve with a value of 0.6, I completely agree with you. Now, concerning the strategy with the Y-graft configuration, we have published, and the Japanese team, mainly Nakajima, has published, that the use of the Y-graft configuration, and mainly where the right coronary artery is not occluded or sub occluded, you definitely increase the rate of competition flow and thereby the rate of occlusion of the distal portion of the right mammary. So today in my everyday practice when, unfortunately, the right is not occluded or sub occluded, which is the case in nearly 60% of the patients in three-vessel disease, I don't go to the right system with the right mammary and a Y-graft configuration, I prefer to use a third arterial graft or a venous graft, depending on the degree of stenosis. Now, it's a very hot topic and we don't have yet the answers, but we've discussed that yesterday afternoon in the coronary session. I definitely think that we should, when there is doubt on the severity of the stenosis on the right coronary system, we should ask our cardiologists to perform a fractional flow reserve measurement in order to really know if the lesion is significant or not. So if it's not significant, we should not treat it and stop grafting unnecessary non-stenotic vessels.
Dr Davierwala: Thanks for your comments and again very impressed with the good results, especially complete revascularization with a mean of four grafts per patient.
